Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5021 results
Water Street enters into pharmaceutical development partnership
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced that it has formed a pharmaceutical development partnership with one of the world's leading global health care companies.
Drug Research > Drug Discovery & Development > News
Visterra, A*STAR to develop monoclonal antibody VIS513 to treat dengue
By PBR Staff Writer
US-based biotechnology firm Visterra and the Drug Discovery & Development (D3) unit under the Agency for Science, Technology and Research (A*STAR), Singapore, have collaborated to further the development of VIS513, Visterra’s neutralizing antibody to treat dengue fever.
Drug Research > Drug Discovery & Development > News
R-Tech Ueno completes Phase I single-dose trial for new VAP-1 Inhibitor RTU-1096
By PBR Staff Writer
Japan-based pharmaceutical venture business R-Tech Ueno has completed the Phase I single-dose clinical trial for the new molecular entity RTU-1096, a vascular adhesion protein-1 (VAP-1) inhibitor having anti-inflammatory and immunomodulatory effects.
Drug Research > Drug Discovery & Development > News
Regeneron, Sanofi report positive topline results from Phase III trials with sarilumab in patients with rheumatoid arthritis
Regeneron Pharmaceuticals, and Sanofi announced that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Drug Research > Drug Discovery & Development > News
Growing Potential: mAb Production With Fibra-Cel
| By Eppendorf
The market for monoclonal antibodies continues to grow steadily, but there are still bottlenecks in the development of new products, including long development times mostly due to R&D. Advanced bioprocess equipment that meets the specific demands of mAb-producing hybridoma can accelerate design and production, and reduce overall development costs along the way.
Drug Research > Drug Discovery & Development > White Papers
DoE Bioprocess Development
| By Eppendorf
Eppendorf DASware is the effective route to design of experiments (DoE) in early-stage bioprocess development. Claudia M Huether-Franken and Sebastian Kleebank explain how the design software applies DoE to DASGIP parallel bioreactor systems.
Drug Research > Drug Discovery & Development > White Papers
Taking the Strain
| By Eppendorf
Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line - used worldwide and approved by the US Food and Drug Administration - as well as media technology and the bioreactor options available.
Drug Research > Drug Discovery & Development > White Papers
SignalRx gets STTR grant from NIH to develop dual PI3 kinase/bromodomain inhibitors as anticancer agents
SignalRx Pharmaceuticals, focused on developing more effective oncology drugs though molecular design imparting selective multiple target inhibition, announced that it has received non-dilutive funding to advance the preclinical development of unique small molecule inhibitors designed to inhibit multiple critical cancer targets.
Drug Research > Drug Discovery & Development > News
Faron, China Medical System to develop traumakine to treat ARDS
By PBR Staff Writer
Finnish biopharmaceutical firm Faron, China Medical Systems (CMS) and A&B have entered into a strategic agreement to develop and commercialize traumakine to treat moderate to severe acute respiratory distress syndrome (ARDS).
Drug Research > Drug Discovery & Development > News
Designing Wellness for Fun and Satisfaction: Gummies - Based Nutrition
| By Softigel pbr
The gummy delivery form for vitamins, minerals and supplements is the single-largest source of growth among the supplements category. Vitamin users report preference for gummy/soft chewable products because these offer not only pleasure and a fun experience, but efficacy and convenience. The selection of materials during the design process of the formula is critical for the final product in order to meet the expectations of the consumers, which is to find a healthy product that will give them a delicious reward as well. Based on the design and development process, this paper reviews review in detail the stage of selection of materials and validation as a critical phase to obtain a product that represents quality and stability as well as the specific requirements of the costumers and the consumers.
Drug Research > Drug Discovery & Development > White Papers
RadioMedix, Areva Med to develop new treatment against NETs
By PBR Staff Writer
US-based biotechnology firm RadioMedix has entered into an agreement with Areva Med to jointly develop a new treatment against neuroendocrine tumors (NETs) using Targeted Alpha Therapy with lead-212 (212Pb).
Drug Research > Drug Discovery & Development > News
Roche reports positive interim results from Phase II trial of MPDL3280A
Roche announced interim results from a global, randomised Phase II study (POPLAR) in people with previously treated NSCLC.
Drug Research > Drug Discovery & Development > News
Fibromyalgia treatment market value will crawl to $1.9bn by 2023, says GlobalData
The treatment market value for fibromyalgia across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will expand from $1.8 billion in 2013 at a tepid Compound Annual Growth Rate (CAGR) of 0.72% to reach $1.9 billion by 2023, according to research and consulting firm GlobalData.
Drug Research > Drug Discovery & Development > News
D-Pharm gets final report for Phase II trial of THR-18 in acute stroke patients treated With tPA
D-Pharm has received the final report for its Phase 2 clinical study of THR-18. THR-18 demonstrated statistically significant reductions in the incidence of intracranial hemorrhage (ICH), brain swelling (edema) and a satisfactory safety profile in stroke patients treated with tPA.
Drug Research > Drug Discovery & Development > News
Cyclenium, Astellas Pharma enter into drug discovery collaboration
By PBR Staff Writer
US-based Cyclenium Pharma has entered into a two-year drug discovery collaboration agreement with Japanese firm Astellas Pharma.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Therapure Biopharma - Contract Protein Development and Manufacturing
Therapure Biopharma is a Contract Development and Manufacturing Organization (CDMO) that specializes in the development, scale up and manufacture of complex biologics. ... Drug Research > Drug Discovery & Development > Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
ERT - Getting it done. Right.
ERT is a leading global provider of high-quality patient safety and efficacy endpoint data collection solutions for use by biopharmaceutical companies during clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle.... Drug Research > Drug Discovery & Development > Suppliers
Eppendorf - We Know Bioprocessing
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO² incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Growing Potential: mAb Production With Fibra-Cel By Eppendorf
The market for monoclonal antibodies continues to grow steadily, but there are still bottlenecks in the development of new products, including long development times mostly due to R&D. Advanced bioprocess equipment that meets the specific demands of mAb-producing hybridoma can accelerate design and production, and reduce overall development costs along the way.... Drug Research > Drug Discovery & Development > White Papers DoE Bioprocess Development By Eppendorf
Eppendorf DASware is the effective route to design of experiments (DoE) in early-stage bioprocess development. Claudia M Huether-Franken and Sebastian Kleebank explain how the design software applies DoE to DASGIP parallel bioreactor systems.... Drug Research > Drug Discovery & Development > White Papers Taking the Strain By Eppendorf
Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line - used worldwide and approved by the US Food and Drug Administration - as well as media technology and the bioreactor options available.... Drug Research > Drug Discovery & Development > White Papers Designing Wellness for Fun and Satisfaction: Gummies - Based Nutrition By Softigel pbr
The gummy delivery form for vitamins, minerals and supplements is the single-largest source of growth among the supplements category. Vitamin users report preference for gummy/soft chewable products because these offer not only pleasure and a fun experience, but efficacy and convenience. The selection of materials during the design process of the formula is critical for the final product in order to meet the expectations of the consumers, which is to find a healthy product that will give them a delicious reward as well. Based on the design and development process, this paper reviews review in detail the stage of selection of materials and validation as a critical phase to obtain a product that represents quality and stability as well as the specific requirements of the costumers and the consumers.... Drug Research > Drug Discovery & Development > White Papers A High Quality Formulation Development and Manufacturing Company By Alpex Pharma
Our predominant focus is the development of solid dosage forms to deliver drugs directly into the oral cavity in order to potentially improve both the bioavailablity of the drug as well as patient compliance and convenience to it. Alpex Pharma has 28 years of cGMP manufacturing experience and formulation development.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5021 results